April 4, 2019

Don’t let Big Pharma lock in high drug prices

No one should have to choose between lifesaving medication and putting food on the table.

And yet: The price of insulin has skyrocketed 700 percent in the last 20 years. The price for a drug to treat parasites, Daraprim, went from $13.50 per pill to $750 per pill overnight. Big Pharma corporations have taken to radically increasing drug prices for some drugs that are in short supply — forcing people like you and me to make difficult, desperate decisions.

In fact, people in the U.S. spend more on prescription drugs than anyone else in the world. Why? Pharmaceutical corporations wildly inflate drug prices — and have rigged the political system. Now, Big Pharma could employ its gouging tactics in Mexico and Canada too.

Here’s why: The revised trade deal between the United States, Mexico, and Canada would extend monopoly rights for pharmaceutical corporations to limit generic competition.

Enough is enough.

Add your name to stop this handout to Big Pharma.

Sky-high drug costs are a matter of life and death for many. Yet if a revised NAFTA deal goes through as written, those high drug costs would be locked in — and limit future Congresses from attempting to lower them. This is just one example of how international trade deals favor corporate interests, and hurt people.

We still have a chance to shape this trade deal and remove some of these egregious provisions — if Congress hears from enough people like you before they ratify the deal. That’s why we’re joining a coalition of organizations to mobilize hundreds of thousands of people to take action.

Urge your lawmakers to remove handouts to Big Pharma from the revised NAFTA deal before Congress begins to consider it.

We can’t afford a trade deal that protects Big Pharma’s profits at the expense of people’s lives. Add your name to challenge Big Pharma’s abuses and demand a trade deal that works for people.

Corporate Accountability
Our Movement Needs You
You’ll receive email action alerts from Corporate Accountability.

Corporate Accountability is looking for a new Executive Director